Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002546 · ClinicalTrials.gov registry record · Phase 3
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
A Phase 3 study of Sarcoma, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 216
- Enrollment target
- 20
- Study locations
NCT00002546 is a Phase 3 study of Sarcoma that has completed, run by Gynecologic Oncology Group. The registered enrollment target is 216 participants, below the 919-participant average among 122 other Sarcoma trials with a reported enrollment target (76% lower). The trial reports 20 study locations across 11 states.
The verdict
NCT00002546, a Phase 3 study of Sarcoma, has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 216 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether radiation therapy is more effective than combination chemotherapy in treating patients with cancer of the uterus. PURPOSE: This randomized phase III trial is studying radiation therapy to see how well it works compared to combination chemotherapy in treating patients with cancer of the uterus.
Conditions Studied
Interventions
- DRUG cisplatin
- RADIATION radiation therapy
- DRUG ifosfamide
- PROCEDURE adjuvant therapy
Study Locations (20)
Illinois
- Rush University Medical Center - Chicago
- MBCCOP - University of Illinois at Chicago - Chicago
- University of Chicago Cancer Research Center - Chicago
- CCOP - Central Illinois - Decatur
- CCOP - Evanston - Evanston
- - Hinsdale
- CCOP - Carle Cancer Center - Urbana
Indiana
- Indiana University Cancer Center - Indianapolis
- CCOP - Northern Indiana CR Consortium - South Bend
- Saint Joseph Regional Medical Center - South Bend
California
- Women's Cancer Center - Los Gatos - Los Gatos
- Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center - Orange
Alabama
- University of Alabama at Birmingham Comprehensive Cancer Center - Birmingham
Arizona
- CCOP - Western Regional, Arizona - Phoenix
Colorado
- University of Colorado Cancer Center at University of Colorado Health Sciences Center - Denver
Delaware
- CCOP - Christiana Care Health Services - Newark
District of Columbia
- Walter Reed Army Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 1993-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002546
The ClinicalTrials.gov registry entry for NCT00002546 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 919-participant average among 122 other Sarcoma trials with a reported enrollment target (76% lower). The listed sponsor is Gynecologic Oncology Group, which has 154 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sarcoma appearing as the primary indexed condition, and to 4 interventions - of which cisplatin is the first listed.
NCT00002546 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Illinois, Indiana, California.
Frequently Asked Questions
What is clinical trial NCT00002546 about?
NCT00002546 is a clinical study titled "Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether radiation therapy is more effective than combination chemotherapy in treating patients ...
What is the current status of trial NCT00002546?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 216 participants. The study started on 1993-12.
What conditions does trial NCT00002546 study?
This clinical trial studies the following conditions: Sarcoma.
What interventions are being tested in trial NCT00002546?
The interventions under investigation include: cisplatin (DRUG), radiation therapy (RADIATION), ifosfamide (DRUG), adjuvant therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00002546?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002546 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy
ACTIVE NOT RECRUITING · Phase 3
-
Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis
COMPLETED · Phase 3
-
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
COMPLETED · Phase 3
-
A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families
COMPLETED · Phase 3
-
Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
COMPLETED · Phase 3
-
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.